1. Home
  2. EXG vs HCM Comparison

EXG vs HCM Comparison

Compare EXG & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

EXG

Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$9.58

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$11.40

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXG
HCM
Founded
N/A
2000
Country
United States
Hong Kong
Employees
N/A
1796
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.3B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EXG
HCM
Price
$9.58
$11.40
Analyst Decision
Sell
Analyst Count
0
1
Target Price
N/A
$13.75
AVG Volume (30 Days)
439.7K
30.7K
Earning Date
01-01-0001
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.60
Revenue Next Year
N/A
$15.62
P/E Ratio
N/A
$5.49
Revenue Growth
N/A
N/A
52 Week Low
$8.25
$11.10
52 Week High
$9.78
$19.50

Technical Indicators

Market Signals
Indicator
EXG
HCM
Relative Strength Index (RSI) 62.25 25.05
Support Level $9.46 N/A
Resistance Level $9.74 $15.59
Average True Range (ATR) 0.12 0.35
MACD 0.01 -0.06
Stochastic Oscillator 82.65 15.76

Price Performance

Historical Comparison
EXG
HCM

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: